BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33341198)

  • 1. Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus.
    McNamara K; Hughes OB; Strowd LC
    Clin Dermatol; 2020; 38(6):641-647. PubMed ID: 33341198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
    Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
    Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
    Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric drug eruptions.
    Nguyen E; Gabel CK; Yu J
    Clin Dermatol; 2020; 38(6):629-640. PubMed ID: 33341197
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous Cutaneous Drug Eruptions: A Systematic Review.
    Shah N; Shah M; Drucker AM; Shear NH; Ziv M; Dodiuk-Gad RP
    Am J Clin Dermatol; 2021 Jan; 22(1):39-53. PubMed ID: 33108647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
    Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
    Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising trends of symmetrical drug related intertriginous and flexural exanthem due to Itraconazole in patients with superficial dermatophytosis: A case series of 12 patients from eastern part of India.
    Hassanandani T; Panda M; Agarwal A; Das A
    Dermatol Ther; 2020 Nov; 33(6):e13911. PubMed ID: 32594647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A challenging case: Symmetrical drug related intertriginous and flexural exanthem, fixed drug eruption, or both?
    Özkaya E; Babuna G
    Pediatr Dermatol; 2011; 28(6):711-714. PubMed ID: 22082466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 14. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings.
    Çakıcı ÖA; Güder S; Salman A; Ergun T
    Indian J Dermatol Venereol Leprol; 2022; 88(6):814-816. PubMed ID: 36332096
    [No Abstract]   [Full Text] [Related]  

  • 15. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
    Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
    Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
    Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
    Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
    [No Abstract]   [Full Text] [Related]  

  • 17. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.
    Yanes DA; Mosser-Goldfarb JL
    Pediatr Dermatol; 2017 Jan; 34(1):e30-e31. PubMed ID: 27813209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate.
    Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I
    Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.